The β2-Adrenoceptor Subpopulation and Its Contribution to Force Generation in Human Ventricular Myocardium
In the failing human heart, there is a downregulation of cardiac β-adrenoceptors (Bristow et al. 1982, 1984; Ginsburg et al. 1983; Böhm et al. 1988a). As a consequence, the positive inotropic effect of β-adrenoceptor agonist is reduced under experimental (Bristow et al. 1982; Fowler et al. 1986; Böhm et al. 1988a, b) and clinical conditions (Colucci et al. 1988). Increased levels of noradrenaline, imposing a permanent β-adrenergic stimulus on the heart of patients with heart failure (Chidsey et al. 1962, Cohn et al. 1984), are regarded to initiate β-adrenoceptor downregulation. Since noradrenaline primarily stimulates β1-adrenoceptors (Gille et al. 1985) one would expect that β1-adrenoceptors are more affected by downregulation than the β2-adrenoceptor subpopulation. If this is true, the stimulation of β2-adrenoceptors which have been identified in the human myocardium by radioligand-and functional studies (Brodde et al. 1983, 1984, 1986) could be a usefull pathway to increase force of contraction in heart failure. Therefore, cardiac β-adrenoceptors and the β1- and β2-adrenoceptor subpopulation were studied with radioligand binding experiments. Moreover, the effect of the β2-adrenoceptor agonist dopexamine (Brown et al. 1985; Smith et al. 1987) on force of contraction and adenylate cyclase activity was studied in isolated myocardium from failing hearts.
Key wordsβ2-adrenoceptor Heart failure Positive inotropic effect Human myocardium
Unable to display preview. Download preview PDF.
- Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB (1986) (31- and 132-Adrenergic receptor subpopulatons in non-failing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective ß1-receptor down-regulation in heart failure. Circ Res 59: 297–309Google Scholar
- Brodde OE, Schüler S, Kretsch R, Brinkmann M, Borst HG, Hetzer R, Reidemeister JCh, Warnecke H, Zerkowski HR (1986) Regional distribution of ß-adrenoceptors in the human heart: coexistence of functional (31- and ß2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol 8:1235 —1242Google Scholar
- Colucci WS, Leatherman GF, Ludmer PL, Gauthier DF (1987) ß-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion. Circ Res 61 [Suppl I1: 82–86Google Scholar
- Gille E, Lemoine H, Ehle B, Kaumann AJ (1985) The affinity of (—)-propranolol for and 132adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (—)-noradrenaline and (—)-adrenaline. Naunyn-Schmiedebergs Arch Pharmacol 331: 60–70Google Scholar